StockNews.AISignal intelligence
HealthEquity, Inc. · NASDAQ · Healthcare
Browse public HQY signals with their source context and measured market impact. Open any signal for its permanent analysis page.
HQY reported Q2 earnings of $1.08 per share, exceeding estimates. Revenue for Q2 reached $325.83 million, beating analyst predictions. Total HSAs increased to 10 million, a 6% rise year-over-year. HSA assets grew to $33.1 billion, reflecting a 12% increase. Q2 outlook raised for adjusted EPS and revenue guidance.
View signal analysisHQY expects Q2 earnings of 92 cents per share, up from 86 cents. Revenue projected at $320.69 million, exceeding last year's $299.93 million. First-quarter earnings of 97 cents surpassed estimates of 88 cents. Barrington Research maintains an Outperform rating with a $125 price target. Raymond James raised price target from $115 to $120, maintaining Strong Buy rating.
View signal analysisHealthEquity reported Q1 earnings of 97 cents per share, exceeding expectations. Quarterly revenue reached $330.8 million, surpassing analyst estimates. The company raised its fiscal 2026 EPS guidance to between $3.61 and $3.78. Shares increased 9.8% following the positive earnings report. Analysts adjusted price targets, signaling bullish sentiment on HQY.
View signal analysisHealthEquity (HQY) announces earnings on June 3, 2025. Historically, HQY shows a 70% chance of positive post-earnings returns. Analysts expect HQY to earn $0.81 per share, up from $0.80. Over the past year, HQY reported $1.2 billion in revenue. The stock has a market cap of $8.7 billion.
View signal analysisHealthEquity will report Q4 earnings on March 18, estimating 72 cents per share. Projected revenue of $305.82 million shows significant growth from last year. Shares recently increased by 3.4%, closing at $100.72 on Monday. Multiple analysts maintain positive ratings with price targets between $112 to $126. Prior mixed results in Q3 may influence market perceptions ahead of earnings.
View signal analysisHealthEquity's profit outlook missed analyst estimates for fiscal 2025. Quarterly results showed a 21% revenue increase year-over-year. The number of health savings accounts rose by 15% to 9.5 million. Annual EPS expectations are $3.08 to $3.16, below analyst forecasts. Shares dropped over 6% despite a 43% gain year-to-date.
View signal analysis